Biogen BIIB stock has declined 21.4% in the past three months against a decrease of 12.3% for the industry. The stock has also underperformed the sector and the S&P 500 index, as seen in the chart ...

Private Medicare plans must cover Biogen's ALS drug, US agency says Healthcare & Pharmaceuticalscategory· December 13, 2024 Corcept Therapeutics said on Wednesday its experimental drug failed to ...

What risks does Biogen face from pipeline setbacks and increasing competition? Recent pipeline setbacks, such as the discontinuation of SAGE-324, have increased the pressure on Biogen's remaining ...

Biogen Pharmachem Industries Ltd was formerly incorporated as Wellworth Overseas Limited in July 1995. The name of the Company was changed to Sun Techno Overseas Limited in August 2011 and again the ...

Biogen's Earnings Growth And 9.9% ROE On the face of it, Biogen's ROE is not much to talk about. We then compared the company's ROE to the broader industry and were disappointed to see that the ...